| # | Drug | Count |
|---|---|---|
| 0 | ACETAMINOPHEN | 67 |
| 1 | ACETAMINOPHEN 500MG | 54 |
| 2 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 54 |
| 3 | PAIN RELIEVER | 54 |
| 4 | ALEMTUZUMAB | 50 |
| 5 | METHYLPREDNISOLONE | 46 |
| 6 | DIMENHYDRINATE | 45 |
| 7 | LAMOTRIGINE | 45 |
| 8 | ERGOCALCIFEROL | 41 |
| 9 | RANITIDINE | 33 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ADENINE | 1 | 0.0204 |
| 1 | BENZETHONIUM CHLORIDE 0.13% | 1 | 0.0152 |
| 2 | VALERIAN ROOT, PASSIFLORA, MAGNESIUM CARBONATE | 2 | 0.0108 |
| 3 | ATRASENTAN | 1 | 0.0099 |
| 4 | NYSTATIN AND TRIAMCINOLONE ACETONIDE | 1 | 0.0095 |
| 5 | NYSTATIN, TRIAMCINOLONE ACETONIDE | 1 | 0.0092 |
| 6 | LULICONAZOLE | 1 | 0.0057 |
| 7 | DIMENHYDRINATE | 45 | 0.0042 |
| 8 | DELGOCITINIB | 1 | 0.0037 |
| 9 | ADO-TRASTUZUMAB EMTANSINE | 27 | 0.0032 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 99 |
| 1 | Corticosteroid [EPC] | 62 |
| 2 | Mood Stabilizer [EPC] | 60 |
| 3 | Anti-epileptic Agent [EPC] | 53 |
| 4 | Benzodiazepine [EPC] | 53 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 50 |
| 6 | Atypical Antipsychotic [EPC] | 43 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 35 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 26 |
| 9 | HER2/neu Receptor Antagonist [EPC] | 25 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD52-directed Cytolytic Antibody [EPC] | 50 | 0.0026 |
| 1 | Tricyclic Antidepressant [EPC] | 1 | 0.0021 |
| 2 | 5-Lipoxygenase Inhibitor [EPC] | 1 | 0.0015 |
| 3 | Interferon gamma [EPC] | 2 | 0.0014 |
| 4 | Nucleoside Analog Antifungal [EPC] | 2 | 0.0014 |
| 5 | Cortisol Synthesis Inhibitor [EPC] | 1 | 0.0013 |
| 6 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0006 |
| 7 | Carnitine Analog [EPC] | 2 | 0.0005 |
| 8 | Provitamin D2 Compound [EPC] | 12 | 0.0004 |
| 9 | Antimycobacterial [EPC] | 9 | 0.0004 |